The pharmaceutical industry has shown a hostility to e-cigarettes because they present a direct threat to pharmaceutical products.
Liz Mair, Vapers United, Arlington, Va.
My heart goes out to Sen. Jeff Stone. I have seen family members die painful and drawn-out deaths as a result of smoking-related illnesses. A deep fear of ending up in the same plight is what drove me to quit smoking, via vaping. My personal experiences run counter to what Sen. Stone is suggesting. I no longer smoke or vape or intake nicotine through any non-food means.
I strongly urge Sen. Stone not to discount the experiences of many vapers and former vapers who have proven that vaping can be a pathway to quitting smoking.
Products like Chantix, nicotine gum, and the patch do not work for everyone.
The pharmaceutical industry has shown a hostility to e-cigarettes because, in my opinion, they present a direct threat to pharmaceutical products dominating the market where products that smokers may use to try to quit smoking are concerned.
It is all too easy for anti-vapor advocates to inadvertently wind up doing the bidding of Big Tobacco and Big Pharma, which benefit from vapor crackdowns. Tobacco stock prices went up on the day U.S. Food & Drug Administration Commissioner Scott Gottlieb announced his vapor crackdown last year.
Anyone who is concerned about bringing smoking rates down needs to consider that they may be aiding entities they literally view as the devil incarnate: Principally Big Tobacco, but in the case of some progressives especially, also Big Pharma.